Cargando…

An activity-based functional test for identifying homologous recombination deficiencies across cancer types in real time

Homologous recombination (HR)-mediated DNA repair is a prerequisite for maintaining genome stability. Cancer cells displaying HR deficiency (HRD) are selectively eliminated by poly(ADP-ribose) polymerase inhibitors (PARPis). To date, sequencing of HR-associated genes and analyzing genome instability...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Chih-Ying, Cheng, Wen-Fang, Lin, Po-Han, Chen, Yu-Li, Huang, Shih-Han, Lei, Kai-Hang, Chang, Ko-Yu, Ko, Min-Yu, Chi, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10694588/ https://www.ncbi.nlm.nih.gov/pubmed/37863059 http://dx.doi.org/10.1016/j.xcrm.2023.101247

Ejemplares similares

Genomic and molecular landscape of homologous recombination deficiency across multiple cancer types
por: Shi, Zhiwen, et al.
Publicado: (2023)

The RECAP Test Rapidly and Reliably Identifies Homologous Recombination-Deficient Ovarian Carcinomas
por: van Wijk, Lise M., et al.
Publicado: (2020)

Homologous Recombination Deficiency Assays in Epithelial Ovarian Cancer: Current Status and Future Direction
por: Chiang, Ying-Cheng, et al.
Publicado: (2021)

Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types
por: Takamatsu, Shiro, et al.
Publicado: (2021)

Genomic Determinants of Homologous Recombination Deficiency across Human Cancers
por: Qing, Tao, et al.
Publicado: (2021)

Utility of Homologous Recombination Deficiency Biomarkers Across Cancer Types
por: Takamatsu, Shiro, et al.
Publicado: (2022)

Differential whole-genome doubling and homologous recombination deficiencies across breast cancer subtypes from the Taiwanese population
por: Wu, Chia-Hsin, et al.
Publicado: (2021)

Homologous Recombination Deficiencies and Hereditary Tumors
por: Yamamoto, Hideki, et al.
Publicado: (2021)

Biomarkers for Homologous Recombination Deficiency in Cancer
por: Wagener-Ryczek, Svenja, et al.
Publicado: (2021)

Functional RECAP (REpair CAPacity) assay identifies homologous recombination deficiency undetected by DNA-based BRCAness tests
por: Meijer, Titia G., et al.
Publicado: (2022)

Targeting homologous recombination deficiency in uterine leiomyosarcoma
por: Dall, Genevieve, et al.
Publicado: (2023)

Homologous Recombination Deficiency Testing for BRCA-Like Tumors: The Road to Clinical Validation
por: Ladan, Marjolijn M., et al.
Publicado: (2021)

Pan-cancer landscape of homologous recombination deficiency
por: Nguyen, Luan, et al.
Publicado: (2020)

Determinants of Homologous Recombination Deficiency in Pancreatic Cancer
por: Wattenberg, Max M., et al.
Publicado: (2021)

Homologous Recombination Deficiency: Concepts, Definitions, and Assays
por: Stewart, Mark D, et al.
Publicado: (2022)

Leveraging homologous recombination repair deficiency in sarcoma
por: Slade, Dea, et al.
Publicado: (2023)

Homologous Recombination Deficiency (HRD) in Cutaneous Oncology
por: Akinjiyan, Favour A., et al.
Publicado: (2023)

A Systematic Review and Meta-Analysis on the Prognostic Value of BRCA Mutations, Homologous Recombination Gene Mutations, and Homologous Recombination Deficiencies in Cancer
por: Shao, Changxia, et al.
Publicado: (2022)

Homologous Recombination Repair Deficiency and Implications for Tumor Immunogenicity
por: van Wilpe, Sandra, et al.
Publicado: (2021)

The Utility of NGS Analysis in Homologous Recombination Deficiency Tracking
por: Tsantikidi, Aikaterini, et al.
Publicado: (2023)

Validation of genomic and transcriptomic models of homologous recombination deficiency in a real-world pan-cancer cohort
por: Leibowitz, Benjamin D., et al.
Publicado: (2022)

Homologous Recombination Deficiency Landscape of Breast Cancers and Real-World Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Patients With Somatic BRCA1/2, Germline PALB2, or Homologous Recombination Deficiency Signature
por: Batalini, Felipe, et al.
Publicado: (2023)

Mapping global and local coevolution across 600 species to identify novel homologous recombination repair genes
por: Sherill-Rofe, Dana, et al.
Publicado: (2019)

Homologous recombination deficiency (HRD) testing in ovarian cancer clinical practice: a review of the literature
por: Frey, Melissa K., et al.
Publicado: (2017)

Homologous recombination deficiency (HRD) testing on cell-free tumor DNA from peritoneal fluid
por: Roussel-Simonin, Cyril, et al.
Publicado: (2023)

Haploidization in Saccharomyces cerevisiae Induced by a Deficiency in Homologous Recombination
por: Song, Wei, et al.
Publicado: (2012)

Multi-scale characterisation of homologous recombination deficiency in breast cancer
por: Jacobson, Daniel H., et al.
Publicado: (2023)

Methylation‐ and homologous recombination deficiency‐related mutant genes predict the prognosis of lung adenocarcinoma
por: Nie, Guang‐Jie, et al.
Publicado: (2022)

Homologous recombination–deficient mutation cluster in tumor suppressor RAD51C identified by comprehensive analysis of cancer variants
por: Prakash, Rohit, et al.
Publicado: (2022)

Homologous recombination deficiency serves as a prognostic biomarker in clear cell renal cell carcinoma
por: He, Liping, et al.
Publicado: (2023)

The role of homologous recombination deficiency testing in ovarian cancer and its clinical implications: do we need it?
por: Ngoi, N.Y.L., et al.
Publicado: (2021)

Homologous recombination deficiency is inversely correlated with microsatellite instability and identifies immunologically cold tumors in most cancer types
por: Budczies, Jan, et al.
Publicado: (2022)

SLC26A4 correlates with homologous recombination deficiency and patient prognosis in prostate cancer
por: Luo, Cong, et al.
Publicado: (2022)

Identification of biomarkers complementary to homologous recombination deficiency for improving the clinical outcome of ovarian serous cystadenocarcinoma
por: Shi, Zhiwen, et al.
Publicado: (2021)

Potential value of the homologous recombination deficiency signature we developed in the prognosis and drug sensitivity of gastric cancer
por: Wu, Xin, et al.
Publicado: (2022)

Homologous Recombination in Negative Sense RNA Viruses
por: Han, Guan-Zhu, et al.
Publicado: (2011)

Intra-Molecular Homologous Recombination of Scarless Plasmid
por: Liang, Yaping, et al.
Publicado: (2020)

Homologous recombination-deficient tumors are hyper-dependent on POLQ-mediated repair
por: Ceccaldi, Raphael, et al.
Publicado: (2015)

Race-Specific Genetic Profiles of Homologous Recombination Deficiency in Multiple Cancers
por: Hsiao, Yi-Wen, et al.
Publicado: (2021)

Homologous Recombination Deficiency Scar: Mutations and Beyond—Implications for Precision Oncology
por: van der Wiel, Alexander M. A., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b3hl7i7s3tt44r5dlstu2qq0p9